Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinqi Liu

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Plants (Basel, Switzerland)|August 14, 2025
Salt Stress Responses of Different Rice Varieties at Panicle Initiation: Agronomic Traits, Photosynthesis, and AntioxidantsYusheng Li, Yuxiang Xue, Zhuangzhuang Guan, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 7, 2018
Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS/MSYing Chen, Olga Berejnaia, Jinqi Liu, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Annals of the Rheumatic Diseases|July 9, 2026
A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trialPaul Emery, Michael E Weinblatt, Vivian P Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritisJinqi Liu, Yicong Li, Kai Fu, et al.
Plos One|January 22, 2013
Diacylglycerol acyltransferase-1 (DGAT1) inhibition perturbs postprandial gut hormone releaseHua V Lin, Dunlu Chen, Zhu Shen, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Arthritis Research & Therapy|August 31, 2024
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Novel pyrrolidine heterocycles as CCR1 antagonistsJ Robert Merritt, Ray James, Vidyadhar M Paradkar, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Plants (Basel, Switzerland)|August 14, 2025
Salt Stress Responses of Different Rice Varieties at Panicle Initiation: Agronomic Traits, Photosynthesis, and AntioxidantsYusheng Li, Yuxiang Xue, Zhuangzhuang Guan, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 7, 2018
Quantifying ceramide kinetics in vivo using stable isotope tracers and LC-MS/MSYing Chen, Olga Berejnaia, Jinqi Liu, et al.
RMD Open|December 30, 2022
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritisChun Wu, Yanhua Hu, Peter Schafer, et al.
Annals of the Rheumatic Diseases|July 9, 2026
A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trialPaul Emery, Michael E Weinblatt, Vivian P Bykerk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritisJinqi Liu, Yicong Li, Kai Fu, et al.
Plos One|January 22, 2013
Diacylglycerol acyltransferase-1 (DGAT1) inhibition perturbs postprandial gut hormone releaseHua V Lin, Dunlu Chen, Zhu Shen, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Arthritis Research & Therapy|August 31, 2024
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Novel pyrrolidine heterocycles as CCR1 antagonistsJ Robert Merritt, Ray James, Vidyadhar M Paradkar, et al.
Pageof 6